Develops and markets cotton-derived hemostatic gauze for hospitals, clinics and emergency responders treating superficial bleeding.
10-K for FY2025, filed Apr 15, 2026United Health Products, Inc. (“UHP”, “we” or the “Company”) develops, manufactures, and markets a patented hemostatic gauze for the…View ↗
CelluSTAT Hemostatic Gauze (formerly branded as HemoStyp) is a natural substance created from chemically treated cellulose derived from…View ↗
Hospitals and Surgery Centers for all Internal Surgical usage (in the event we obtain FDA Class III approval)View ↗
Hospitals, Clinics and Physicians for external traumaView ↗
EMS, Fire Departments and other First RespondersView ↗
Potential buyers include hospitals and surgery centers, first responders and military medical providers, and veterinary hospitals. Customers order directly from UHP.
10-K for FY2025, filed Apr 15, 2026Our CelluSTAT material is currently cut to several sizes and configurations. While we have paused our commercial activities to focus on our…View ↗
Hospitals and Surgery Centers for all Internal Surgical usage (in the event we obtain FDA Class III approval)View ↗
EMS, Fire Departments and other First RespondersView ↗
Military Medical Care ProvidersView ↗
Veterinary hospitalsView ↗
The Company receives orders for its CelluSTAT products directly from its customers. Revenues are recognized based on the agreed upon sales…View ↗
Sales activity paused
The older report described renewed outreach to consumers and distributors in non-surgical markets; the latest says commercial activity is paused while the company focuses on its regulatory application.
10-K for FY2022, filed Mar 28, 2023 10-K for FY2025, filed Apr 15, 2026In 2018, we made the decision to focus our efforts and resources on accessing these Class III markets to maximize the value potential of…View ↗
Our CelluSTAT material is currently cut to several sizes and configurations. While we have paused our commercial activities to focus on our…View ↗
Competes with Baxter International, Becton Dickinson, Johnson & Johnson, Teleflex, and 3M
10-K for FY2025, filed Apr 15, 2026The wound care products market in the United States is concentrated among large and established companies such as Baxter International…View ↗
Loading...